Table 3.
Number | Pathological signs | Control | Vehicle | Acetaminophen | Saffron 150 | Saffron 300 |
---|---|---|---|---|---|---|
H&E staining | ||||||
1 | Glycogen depletion | 0 | 0 | 1* | 0 | 0 |
2 | Congestion | 0 | 0 | 3*** | 1 | 1 |
3 | Sinusoidal dilation | 0 | 0 | 2*** | 1 | 1 |
4 | Inflammatory infiltration (Lymphocytic infiltration) |
0 | 0 | 2 | 1 | 0 |
5 | Vacuolization | 0 | 0 | 3*** | 1* | 0 |
6 | Bile stasis | 0 | 0 | 2* | 0 | 0 |
7 | Bile plugs | 0 | 0 | 1 | 0 | 0 |
8 | Kuffer cell hyperplasia | 0 | 0 | 2* | 2* | 3*** |
9 | Pyknosis | 0 | 0 | 1 | 0 | 0 |
10 | Necrosis | 0 | 0 | 2* | 0 | 0 |
Reticulin staining | ||||||
Reticulin fibers | 0 | 0 | 2*** | 0### | 0### |
Histological changes were scored as none (0), active damage less than 25% (+), active damage less than 50% (++), active damage less than 75% (+++) damage and active. *Significant differences from the control group (*p≤0.05, **p≤0.01 and ***p≤0.001); #significant differences from the acetaminophen-treated group (###p≤0.001).